966
Views
68
CrossRef citations to date
0
Altmetric
Research Paper

Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation

Pages 404-414 | Received 15 May 2009, Accepted 29 Jun 2009, Published online: 16 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Anna Orlova, Bettina Wingelhofer, Heidi A. Neubauer, Barbara Maurer, Angelika Berger-Becvar, György Miklós Keserű, Patrick T. Gunning, Peter Valent & Richard Moriggl. (2018) Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas. Expert Opinion on Therapeutic Targets 22:1, pages 45-57.
Read now
Jens Przybilla, Lydia Hopp, Michael Lübbert, Markus Loeffler & Joerg Galle. (2017) Targeting DNA hypermethylation: Computational modeling of DNA demethylation treatment of acute myeloid leukemia. Epigenetics 12:10, pages 886-896.
Read now
Bi-Feng Chen & Wai-Yee Chan. (2014) The de novo DNA methyltransferase DNMT3A in development and cancer. Epigenetics 9:5, pages 669-677.
Read now
Francesca Buchi, Erico Masala, Alessia Rossi, Ana Valencia, Elena Spinelli, Alessandro Sanna, Antonella Gozzini & Valeria Santini. (2014) Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. Epigenetics 9:3, pages 387-395.
Read now
Milena Leseva, Katherine E Santostefano, Amy L Rosenbluth, Takashi Hamazaki & Naohiro Terada. (2013) E2f6-mediated repression of the meiotic Stag3 and Smc1β genes during early embryonic development requires Ezh2 and not the de novo methyltransferase Dnmt3b. Epigenetics 8:8, pages 873-884.
Read now
Gauri Deb, Vijay S. Thakur & Sanjay Gupta. (2013) Multifaceted role of EZH2 in breast and prostate tumorigenesis. Epigenetics 8:5, pages 464-476.
Read now
Maureen A. Sartor, Dana C. Dolinoy, Tamara R. Jones, Justin A. Colacino, Mark E.P. Prince, Thomas E. Carey & Laura S. Rozek. (2011) Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics 6:6, pages 777-787.
Read now
Yan-Wei Lin, Hui-Min Chen & Jing-Yuan Fang. (2011) Gene Silencing by the Polycomb Group Proteins and Associations With Cancer. Cancer Investigation 29:3, pages 187-195.
Read now

Articles from other publishers (60)

Badam Enkhmandakh, Pujan Joshi, Paul Robson, Anushree Vijaykumar, Mina Mina, Dong-Guk Shin & Dashzeveg Bayarsaihan. (2023) Single-cell Transcriptome Landscape of DNA Methylome Regulators Associated with Orofacial Clefts in the Mouse Dental Pulp. The Cleft Palate Craniofacial Journal, pages 105566562311722.
Crossref
William A. Pastor & Sin Young Kwon. (2022) Distinctive aspects of the placental epigenome and theories as to how they arise. Cellular and Molecular Life Sciences 79:11.
Crossref
Ting Yang, Xiaobo Liu, Shaji K. Kumar, Fengyan Jin & Yun Dai. (2022) Decoding DNA methylation in epigenetics of multiple myeloma. Blood Reviews 51, pages 100872.
Crossref
Shoji Tajima, Isao Suetake, Kohei Takeshita, Atsushi Nakagawa, Hironobu Kimura & Jikui Song. 2022. DNA Methyltransferases - Role and Function. DNA Methyltransferases - Role and Function 45 68 .
Yang Xie, Feng Wang, Jun Yu, Jing Zhang, Yuting Liu, Mengying Li & Jian Qi. (2021) Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP. Oncology Reports 46:6.
Crossref
Aled Parry, Steffen Rulands & Wolf Reik. (2020) Active turnover of DNA methylation during cell fate decisions. Nature Reviews Genetics 22:1, pages 59-66.
Crossref
Bei Jin, Ping Zhang, Hailin Zou, Huijing Ye, Yun Wang, Jing Zhang, Huasheng Yang & Jingxuan Pan. (2020) Verification of EZH2 as a druggable target in metastatic uveal melanoma. Molecular Cancer 19:1.
Crossref
Yuanhui Jia, Han Xie, Jiqin Zhang & Hao Ying. (2020) Induction of TGF‐β receptor I expression in a DNA methylation‐independent manner mediated by DNMT3A downregulation is involved in early‐onset severe preeclampsia. The FASEB Journal 34:10, pages 13224-13238.
Crossref
Hemalvi Patani, Michael D. Rushton, Jonathan Higham, Saul A. Teijeiro, David Oxley, Pedro Cutillas, Duncan Sproul & Gabriella Ficz. (2020) Transition to naïve human pluripotency mirrors pan-cancer DNA hypermethylation. Nature Communications 11:1.
Crossref
Torsten Thalheim, Lydia Hopp, Maria Herberg, Susann Siebert, Christiane Kerner, Marianne Quaas, Michal R. Schweiger, Gabriela Aust & Joerg Galle. (2020) Fighting Against Promoter DNA Hyper-Methylation: Protective Histone Modification Profiles of Stress-Resistant Intestinal Stem Cells. International Journal of Molecular Sciences 21:6, pages 1941.
Crossref
Christian Pflueger, Tessa Swain & Ryan Lister. (2019) Harnessing targeted DNA methylation and demethylation using dCas9. Essays in Biochemistry 63:6, pages 813-825.
Crossref
Xiaozhen Gu, Yi Xu, Wei-Zhen Xue, Yulan Wu, Zi Ye, Guiran Xiao & Hui-Li Wang. (2019) Interplay of miR-137 and EZH2 contributes to the genome-wide redistribution of H3K27me3 underlying the Pb-induced memory impairment. Cell Death & Disease 10:9.
Crossref
Amal Mechaal, Samia Menif, Salem Abbes & Ines Safra. (2019) EZH2, new diagnosis and prognosis marker in acute myeloid leukemia patients. Advances in Medical Sciences 64:2, pages 395-401.
Crossref
Biji Chatterjee, Krishna Ghosh & Santosh R. Kanade. (2019) Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21 CIP1 in human breast cancer cell lines . BioFactors 45:5, pages 818-829.
Crossref
Daman Kumari, Inbal Gazy & Karen Usdin. (2019) Pharmacological Reactivation of the Silenced FMR1 Gene as a Targeted Therapeutic Approach for Fragile X Syndrome. Brain Sciences 9:2, pages 39.
Crossref
Cameron Lindsay, Morris Kostiuk & Vincent L. Biron. 2019. Pharmacoepigenetics. Pharmacoepigenetics 447 462 .
Marthe Laisné, Nikhil Gupta, Olivier Kirsh, Sriharsa Pradhan & Pierre-Antoine Defossez. (2018) Mechanisms of DNA Methyltransferase Recruitment in Mammals. Genes 9:12, pages 617.
Crossref
Eric Hervouet, Paul Peixoto, Régis Delage-Mourroux, Michaël Boyer-Guittaut & Pierre-François Cartron. (2018) Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma. Clinical Epigenetics 10:1.
Crossref
Katarzyna Polonis, Patrick R. Blackburn, Raul A. Urrutia, Gwen A. Lomberk, Teresa Kruisselbrink, Margot A. Cousin, Nicole J. Boczek, Nicole L. Hoppman, Dusica Babovic-Vuksanovic, Eric W. Klee & Pavel N. Pichurin. (2018) Co-occurrence of a maternally inherited DNMT3A duplication and a paternally inherited pathogenic variant in EZH2 in a child with growth retardation and severe short stature: atypical Weaver syndrome or evidence of a DNMT3A dosage effect? . Molecular Case Studies 4:4, pages a002899.
Crossref
Ying Cai, Jhih-Rong Lin, Quanwei Zhang, Kelly O’Brien, Cristina Montagna & Zhengdong D. Zhang. (2018) Epigenetic alterations to Polycomb targets precede malignant transition in a mouse model of breast cancer. Scientific Reports 8:1.
Crossref
Yanming Wu, Zhao Zhang, Mauro E. Cenciarini, Cecilia J. Proietti, Matias Amasino, Tao Hong, Mei Yang, Yiji Liao, Huai-Chin Chiang, Virginia G. Kaklamani, Rinath Jeselsohn, Ratna K. Vadlamudi, Tim Hui-Ming Huang, Rong Li, Carmine De Angelis, Xiaoyong Fu, Patricia V. Elizalde, Rachel Schiff, Myles Brown & Kexin Xu. (2018) Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2–ERα–GREB1 Transcriptional Axis. Cancer Research 78:3, pages 671-684.
Crossref
Torsten Thalheim, Maria Herberg & Joerg Galle. (2018) Linking DNA Damage and Age-Related Promoter DNA Hyper-Methylation in the Intestine. Genes 9:1, pages 17.
Crossref
Cameron Lindsay, Hadi Seikaly & Vincent L. Biron. (2017) Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets. Journal of Otolaryngology - Head & Neck Surgery 46:1.
Crossref
Henriette O’Geen, Chonghua Ren, Charles M. Nicolet, Andrew A. Perez, Julian Halmai, Victoria M. Le, Joel P. Mackay, Peggy J. Farnham & David J. Segal. (2017) dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression. Nucleic Acids Research 45:17, pages 9901-9916.
Crossref
Torsten Thalheim, Maria Herberg, Markus Loeffler & Joerg Galle. (2017) The Regulatory Capacity of Bivalent Genes—A Theoretical Approach. International Journal of Molecular Sciences 18:5, pages 1069.
Crossref
N A Wijetunga, M Pascual, J Tozour, F Delahaye, M Alani, M Adeyeye, A W Wolkoff, A Verma & J M Greally. (2016) A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets. Oncogene 36:14, pages 2030-2044.
Crossref
Isao Suetake, Mikio Watanebe, Kohei Takeshita, Saori Takahashi & Peter Carlton. 2017. DNA and Histone Methylation as Cancer Targets. DNA and Histone Methylation as Cancer Targets 19 51 .
Yuan-Ming Pan, Cheng-Gang Wang, Min Zhu, Rui Xing, Jian-Tao Cui, Wen-Mei Li, De-Dong Yu, Shu-Bin Wang, Wei Zhu, Ying-Jiang Ye, Yun Wu, Shan Wang & You-Yong Lu. (2016) STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer. Molecular Cancer 15:1.
Crossref
Alireza Lorzadeh, Misha Bilenky, Colin Hammond, David J.H.F. Knapp, Luolan Li, Paul H. Miller, Annaick Carles, Alireza Heravi-Moussavi, Sitanshu Gakkhar, Michelle Moksa, Connie J. Eaves & Martin Hirst. (2016) Nucleosome Density ChIP-Seq Identifies Distinct Chromatin Modification Signatures Associated with MNase Accessibility. Cell Reports 17:8, pages 2112-2124.
Crossref
Hanae Sato, Justin C. Wheat, Ulrich Steidl & Keisuke Ito. (2016) DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders. Frontiers in Oncology 6.
Crossref
Katarzyna Zybura-Broda, Renata Amborska, Magdalena Ambrozek-Latecka, Joanna Wilemska, Agnieszka Bogusz, Joanna Bucko, Anna Konopka, Wieslawa Grajkowska, Marcin Roszkowski, Andrzej Marchel, Andrzej Rysz, Lukasz Koperski, Grzegorz M. Wilczynski, Leszek Kaczmarek & Marcin Rylski. (2016) Epigenetics of Epileptogenesis-Evoked Upregulation of Matrix Metalloproteinase-9 in Hippocampus. PLOS ONE 11:8, pages e0159745.
Crossref
Yanmei Xu, Xia Li, Hongtao Wang, Pengmu Xie, Xun Yan, Yu Bai & Tingguo Zhang. (2016) Hypermethylation of CDH13, DKK3 and FOXL2 promoters and the expression of EZH2 in ovary granulosa cell tumors. Molecular Medicine Reports.
Crossref
Anna Kazanets, Tatiana Shorstova, Khalid Hilmi, Maud Marques & Michael Witcher. (2016) Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1865:2, pages 275-288.
Crossref
Nuno M. C. Martins, Jan H. Bergmann, Nobuaki Shono, Hiroshi Kimura, Vladimir Larionov, Hiroshi Masumoto & William C. Earnshaw. (2016) Epigenetic engineering shows that a human centromere resists silencing mediated by H3K27me3/K9me3. Molecular Biology of the Cell 27:1, pages 177-196.
Crossref
Shoji Tajima, Hironobu Kimura & Isao Suetake. 2016. DNA Replication, Recombination, and Repair. DNA Replication, Recombination, and Repair 489 516 .
Shoji Tajima, Isao Suetake, Kohei Takeshita, Atsushi Nakagawa & Hironobu Kimura. 2016. DNA Methyltransferases - Role and Function. DNA Methyltransferases - Role and Function 63 86 .
Emanuele Libertini, Alice Lebreton, Goran Lakisic, Marie-Agnès Dillies, Stephan Beck, Jean-Yves Coppée, Pascale Cossart & Hélène Bierne. (2015) Overexpression of the Heterochromatinization Factor BAHD1 in HEK293 Cells Differentially Reshapes the DNA Methylome on Autosomes and X Chromosome. Frontiers in Genetics 6.
Crossref
Chen Davidovich & Thomas R. Cech. (2015) The recruitment of chromatin modifiers by long noncoding RNAs: lessons from PRC2. RNA 21:12, pages 2007-2022.
Crossref
Liubin Yang, Rachel Rau & Margaret A. Goodell. (2015) DNMT3A in haematological malignancies. Nature Reviews Cancer 15:3, pages 152-165.
Crossref
Karen A. Lillycrop, Samuel P. Hoile, Leonie Grenfell & Graham C. Burdge. (2014) DNA methylation, ageing and the influence of early life nutrition. Proceedings of the Nutrition Society 73:3, pages 413-421.
Crossref
Ryohei Nakamura, Tatsuya Tsukahara, Wei Qu, Kazuki Ichikawa, Takayoshi Otsuka, Katsumi Ogoshi, Taro L. Saito, Kouji Matsushima, Sumio Sugano, Shinichi Hashimoto, Yutaka Suzuki, Shinichi Morishita & Hiroyuki Takeda. (2014) Large hypomethylated domains serve as strong repressive machinery for key developmental genes in vertebrates. Development 141:13, pages 2568-2580.
Crossref
Xiaorong Gu, Zhenbo Hu, Quteba Ebrahem, John S. Crabb, Reda Z. Mahfouz, Tomas Radivoyevitch, John W. Crabb & Yogen Saunthararajah. (2014) Runx1 Regulation of Pu.1 Corepressor/Coactivator Exchange Identifies Specific Molecular Targets for Leukemia Differentiation Therapy. Journal of Biological Chemistry 289:21, pages 14881-14895.
Crossref
Debra Lyon, Lynne Elmore, Noran Aboalela, Jacqueline Merrill-Schools, Nancy McCain, Angela Starkweather, R. K. ElswickJrJr & Colleen Jackson-Cook. (2013) Potential Epigenetic Mechanism(s) Associated With the Persistence of Psychoneurological Symptoms in Women Receiving Chemotherapy for Breast Cancer. Biological Research For Nursing 16:2, pages 160-174.
Crossref
Katrina Tatton-Brown, Sheila Seal, Elise Ruark, Jenny Harmer, Emma Ramsay, Silvana del Vecchio Duarte, Anna Zachariou, Sandra Hanks, Eleanor O'Brien, Lise Aksglaede, Diana Baralle, Tabib Dabir, Blanca Gener, David Goudie, Tessa Homfray, Ajith Kumar, Daniela T Pilz, Angelo Selicorni, I Karen Temple, Lionel Van Maldergem, Naomi Yachelevich, Robert van Montfort & Nazneen Rahman. (2014) Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nature Genetics 46:4, pages 385-388.
Crossref
J-Y Lee, M K Park, J-H Park, H J Lee, D H Shin, Y Kang, C H Lee & G Kong. (2013) Loss of the polycomb protein Mel-18 enhances the epithelial–mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Oncogene 33:10, pages 1325-1335.
Crossref
O. V. Lukashevich, N. A. Cherepanova, A. Kolbanovsky, N. E. Geacintov & E. S. Gromova. (2014) Benzo[a]pyrene-derived DNA lesions decrease DNA methylation by murine methyltransferase DNMT3A2. Moscow University Chemistry Bulletin 69:2, pages 92-96.
Crossref
Katja Kobow, Antony Kaspi, K. N. Harikrishnan, Katharina Kiese, Mark Ziemann, Ishant Khurana, Ina Fritzsche, Jan Hauke, Eric Hahnen, Roland Coras, Angelika M?hlebner, Assam El-Osta & Ingmar Bl?mcke. (2013) Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathologica 126:5, pages 741-756.
Crossref
Francesco Neri, Anna Krepelova, Danny Incarnato, Mara Maldotti, Caterina Parlato, Federico Galvagni, Filomena Matarese, Hendrik G. Stunnenberg & Salvatore Oliviero. (2013) Dnmt3L Antagonizes DNA Methylation at Bivalent Promoters and Favors DNA Methylation at Gene Bodies in ESCs. Cell 155:1, pages 121-134.
Crossref
D. Sproul & R. R. Meehan. (2013) Genomic insights into cancer-associated aberrant CpG island hypermethylation. Briefings in Functional Genomics 12:3, pages 174-190.
Crossref
Junjie Wang, Lili Yu, Jing Cai, Jinghui Jia, Yanping Gao, Minglin Liang & Zehua Wang. (2013) The role of EZH2 and DNA methylation in hMLH1 silencing in epithelial ovarian cancer. Biochemical and Biophysical Research Communications 433:4, pages 470-476.
Crossref
Anja Schmidt, Heike J. P. Wöhrmann, Michael T. Raissig, Julia Arand, Jacqueline Gheyselinck, Valeria Gagliardini, Christian Heichinger, Joern Walter & Ueli Grossniklaus. (2013) The P olycomb group protein MEDEA and the DNA methyltransferase MET 1 interact to repress autonomous endosperm development in A rabidopsis . The Plant Journal 73:5, pages 776-787.
Crossref
Lingeng Lu, Guangjian Zhu, Chong Zhang, Qian Deng, Dionyssios Katsaros, Susan T. Mayne, Harvey A. Risch, Lina Mu, Emilie Marion Canuto, Gianluca Gregori, Chiara Benedetto & Herbert Yu. (2012) Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Research and Treatment 136:3, pages 875-883.
Crossref
M. L. de Groote, P. J. Verschure & M. G. Rots. (2012) Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Research 40:21, pages 10596-10613.
Crossref
Ewa Dudziec, Andreas Gogol-D?ring, Victoria Cookson, Wei Chen & James Catto. (2012) Integrated Epigenome Profiling of Repressive Histone Modifications, DNA Methylation and Gene Expression in Normal and Malignant Urothelial Cells. PLoS ONE 7:3, pages e32750.
Crossref
Ozren Bogdanović, Steven W. Long, Simon J. van Heeringen, Arie B. Brinkman, Jose Luis Gómez-Skarmeta, Hendrik G. Stunnenberg, Peter L. Jones & Gert Jan C. Veenstra. (2011) Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesis. Genome Research 21:8, pages 1313-1327.
Crossref
Andrew Chase & Nicholas C.P. Cross. (2011) Aberrations of EZH2 in Cancer . Clinical Cancer Research 17:9, pages 2613-2618.
Crossref
Xin-Jian He, Taiping Chen & Jian-Kang Zhu. (2011) Regulation and function of DNA methylation in plants and animals. Cell Research 21:3, pages 442-465.
Crossref
P. Delgado-Olguin & F. Recillas-Targa. (2011) Chromatin structure of pluripotent stem cells and induced pluripotent stem cells. Briefings in Functional Genomics 10:1, pages 37-49.
Crossref
Phillippa C. Taberlay & Peter A. Jones. 2011. Epigenetics and Disease. Epigenetics and Disease 1 23 .
Hao WuVolkan CoskunJifang TaoWei XieWeihong GeKazuaki YoshikawaEn LiYi ZhangYi Eve Sun. (2010) Dnmt3a-Dependent Nonpromoter DNA Methylation Facilitates Transcription of Neurogenic Genes. Science 329:5990, pages 444-448.
Crossref